Clinical Trials Directory

Trials / Completed

CompletedNCT02352090

Synthetic vs Natural Estrogen in Combined Oral Contraception

Synthetic vs Natural Estrogen in Combined Oral Contraception- Effect on Insulin Sensitivity, Coagulation, Inflammation and Endometrium - a Comparison With a Progestin-only Preparation.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
59 (actual)
Sponsor
Helsinki University Central Hospital · Academic / Other
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

The main objective of the study is to compare the metabolic effects of natural estradiol and synthetic ethinylestradiol used in combined oral contraception in healthy women. A progestin-only preparation will be used in comparison. The main goal is to study the effects on glucose metabolism, coagulation and a markers of chronic inflammation (such as hs-CRP). Our hypothesis is that the natural estradiol preparation will influence blood glucose levels, markers of coagulation and chronic inflammation less than the ethinylestradiol preparation. The progestin-only preparation will not effect these parameters.

Conditions

Interventions

TypeNameDescription
DRUGEthinyl estradiol / dienogestOne tablet orally for 9 weeks, continuous use
DRUGEstradiol valerate / dienogestOne tablet orally for 9 weeks, continuous use
DRUGDienogestOne tablet orally for 9 weeks, continuous use

Timeline

Start date
2015-04-01
Primary completion
2018-12-30
Completion
2018-12-30
First posted
2015-02-02
Last updated
2023-06-22
Results posted
2021-06-29

Locations

2 sites across 1 country: Finland

Source: ClinicalTrials.gov record NCT02352090. Inclusion in this directory is not an endorsement.